The protective capacities of histone H1 against experimental murine cutaneous leishmaniasis

By Solioz N.   Blum-Tirouvanziam U.   Jacquet R.   Rafati S.   Corradin G.   Mauel J.   Fasel N.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 850-859

Elsevier

Access to resources Recommend Favorite

Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice

By Fachado A.   Rodriguez A.   Angel S.O.   Pinto D.C.   Vila I.   Acosta A.   Amendoeira R.R.   Lannes-Vieira J.  

Vaccine, Vol. 21, Iss. 13, 2003-03 ,pp. : 1327-1335

Elsevier

Access to resources Recommend Favorite

The role of BCG in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leishmaniasis

By Alimohammadian M.H.   Khamesipour A.   Darabi H.   Firooz A.   Malekzadeh S.   Bahonar A.   Dowlati Y.   Modabber F.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 174-180

Elsevier

Access to resources Recommend Favorite

A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran

By Momeni A.Z.   Jalayer T.   Emamjomeh M.   Khamesipour A.   Zicker F.   Ghassemi R.L.   Dowlati Y.   Sharifi I.   Aminjavaheri M.   Shafiei A.   Alimohammadian M.H.   Hashemi-Fesharki R.   Nasseri K.   Godal T.   Smith P.G.   Modabber F.  

Vaccine, Vol. 17, Iss. 5, 1999-02 ,pp. : 466-472

Elsevier

Access to resources Recommend Favorite

Therapy of murine cutaneous leishmaniasis by DNA vaccination

By Handman E.   Noormohammadi A.H.   Curtis J.M.   Baldwin T.   Sjolander A.  

Vaccine, Vol. 18, Iss. 26, 2000-07 ,pp. : 3011-3017

Elsevier

Access to resources Recommend Favorite